Circulating Thrombopoietin in Clonal Versus Reactive Thrombocytosis

References

• Griesshammer, M., Bangerter, M. and Schrezenmeier, H. (1997) “A possible role for thrombopoietin and its receptor c-Mpl in the pathobiology of essential thrombocythemia”, Semin. Thromb. Hemost. 23, 419–423.
   PubMed Web of Science ®Google Scholar
• Morowitz, D.A., Allen, L.W. and Kirsner, J.B. (1968) “Thrombocytosis associated with chronic inflammatory bowel disease”, Ann. Intern. Med. 18, 1013–1021.
   Google Scholar
• Frenkel, E.P. (1991) “South Western Internal Medicine Conference: the clinical spectrum of thrombocytosis and thrombocythemia”, Am. J. Med. Sci. 301, 69–80.
   PubMed Web of Science ®Google Scholar
• Levin, J. and Conley, C.L. (1964) “Thrombocytosis associated with malignancy”, Arch. Intern. Med. 114, 497–501.
   PubMed Web of Science ®Google Scholar
• Hoffman, R., Mazur, E., Bruno, E. and Floyd, V. (1981) “Assay of an activity in the serum of patients with disorders of thrombopoiesis that stimulates formation of megakaryocyte colonies”, N. Engl. J. Med. 305, 533–538.
   PubMed Web of Science ®Google Scholar
• Mazur, E.M., de Alarcon, P., South, K. and Miceli, L. (1984) “Human serum megakaryocyte colony-stimulating activity increases in response to intensive cytotoxic chemotherapy”, Exp. Hematol. 12, 624–628.
   PubMed Web of Science ®Google Scholar
• Nichol, J.L., Hokom, M.M., Hornkhol, A., et al., (1995) “Megakaryocyte growth and development factor. Analysis of in vitro effect on human megakaryopoiesis and endogenous levels during chemotherapy-induced thrombocytopenia”, J. Clin, westig. 95, 2973–2978.
   Google Scholar
• Chang, M., Suen, Y., Meng, G., Buzby, J., Williams, S., Shen, V., Knoppel, A., Fernandez, G. and Cairo, M.S. (1995) “Regulation of TPO mRNA expression and protein production: TPO gene regulation appears post transcriptional and endogenous level are inversely correlated to megakaryocyte mass and circulating platelet count”, Blood 86 (Suppl. 1), 368.
   Google Scholar
• Shivdasani, R.A., Rosenblatt, M.F., Zucker-Franklin, D., Jackson, C.W., Hunt, P., Saris, C.J.M. and Orkin, S.H. (1995) “Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development”, Cell 81, 695–704.
   PubMed Web of Science ®Google Scholar
• Murphy, S., Iland, H., Rosenthal, D. and Laszlo, J. (1986) “Essential thrombocythemia: an interim report from the polycythemia Vera Study Group”, Semin. Hematol. 23, 177–182.
   PubMed Web of Science ®Google Scholar
• Sungaran, R., Markovic, B. and Chong, B.H. (1997) “Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow and spleen using in situ hybridization”, Blood 89, 101–107.
   PubMed Web of Science ®Google Scholar
• Junzhi Li, Yuping Xia and Kuter, D. (1999) “Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics”, Br. J. Haematol. 106, 345–356.
   PubMed Web of Science ®Google Scholar
• Haznedaroglu, I.C., Ertenli, I., Ozcebe, I.O., Kıraz, S., Ozdemir, O., Sayınalp, N., Dündar, S., Çalgüneri, M. and Kirazlı, Ş (1996) “Megakaryocyte-related interleukins in reactive thrombocytosis versus autonomous thrombocytemia”, Acta Haematol. 95, 107–111.
   PubMed Web of Science ®Google Scholar
• Tefferi, A., Ho, T.C., Ahmann, G.J., Katzmann, J.A. and Greipp, P.R. (1994) “Plasma interleukin-6 and c-reactive protein levels in reactive versus clonal thrombocytosis”, Am. J. Med. 97, 374–378.
   PubMed Web of Science ®Google Scholar
• Hsu, H.C., Tsai, W.H., Jiang, M.L., Ho, C.H., Hsu, M.L., Ho, C.K. and Wang, S.Y. (1999) “Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis”, J. Lab. Clin. Med. 134, 392–397.
   PubMed Web of Science ®Google Scholar
• Tomita, N., Motomura, S., Sakai, R., et al., (2000) “Strong inverse correlation between serum TPO level and platelet count in essential thrombocythemia”, Am. J. Hematol. 63, 131–135.
   PubMed Web of Science ®Google Scholar
• Pitcher, L., Taylor, K., Nichol, J., Selsi, D., Rodwel, R., Marty, J., Taylor, D., Wright, S., Moore, D., Kelly, C. and Rentoul, A. (1997) “Thrombopoietin measurement in thrombocytosis: dysregulation and lack of feedback inhibition in essential thrombocythaemia”, Br. J. Haematol. 99, 929–932.
   PubMed Web of Science ®Google Scholar
• Cerutti, A., Custodi, P., Curanti, M., Niros, P., Balduini, C.L., et al., (1997) “Thrombopoietin levels in patients with primary and reactive thrombocytosis”, Br. J. Haematol. 99, 281–284.
   PubMed Web of Science ®Google Scholar
• Hou, M., Carneskog, J., Mellqvist, U.H., Stockelberg, D., Hedberg, M., Wadenvik, H., et al., (1998) “Impact of endogenous thrombopoietin levels on the differential diagnosis of essential thrombocythaemia and reactive thrombocytosis”, Eur. J. Haematol. 61,119–122.
   PubMed Web of Science ®Google Scholar
• Griesshammer, M., Hornkohl, A., Nichol, J.L., Ragnavachar, A., Heimpel, H., et al., (1998) “High levels of thrombopoietin in sera of patients with essential thrombocytopenia: cause or consequence of abnormal platelet production”, Ann. Haematol. 77, 211–215.
   PubMed Web of Science ®Google Scholar
• Wang, J.C., Chen, C., Novetsky, A.D., Lichter, S.M., Ahmed, F. and Friedberg, N.M. (1998) “Blood thrombopoietin levels in clonal thrombocytosis and reactive thrombocytosis”, Am. J. Med. 104, 451–455.
   PubMed Web of Science ®Google Scholar
• Uppenkamp, M., Makarova, E., Petrasch, S. and Brittinger, G. (1998) “Thrombopoietin serum concentration in patients with reactive and myeloproliferative thrombocytosis”, Ann. Haematol. 77, 217–223.
   PubMed Web of Science ®Google Scholar
• Harrison, C.N., Gale, R.E., Pezella, F., Mire-Sluis, A., MacHin, S.J. and Linch, D.C. (1999) “Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value”, Br. J. Haematol. 107, 139–147.
   PubMed Web of Science ®Google Scholar
• Cerutti, A., Custodi, P., Duranti, M., Noris, P. and Balduini, C.L. (1997) “Thrombopoietin level in patients with primary and reactive thrombocytosis”, Br. J. Haematol. 99, 281–284.
   PubMed Web of Science ®Google Scholar
• Espanol, I., Hernandez, A., Cortes, M., Mateo, J. and Pujol-Moix, N. (1999) “Patients with thrombocytosis have normal or slightly elevated thrombopoietin levels”, Haematologica 84, 312–316.
   PubMed Web of Science ®Google Scholar
• Taksin, A.L., Couedic, J.P.L., Dusanter-Fourt, I., Masse, A., Giraudier, S., Katz, A., et al., (1999) “Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L”, Blood 93, 125–139.
   PubMed Web of Science ®Google Scholar
• Kiladjian, J.J., Elkassar, N., Hetet, G., Briere, J., Grandchamp, B. and Gardin, C. (1997) “Study of the thrombopoietin receptor in essential thrombocythemia”, Leukemia 11, 1821–1826.
   PubMed Web of Science ®Google Scholar
• Horikawa, Y., Matsumura, I., Hashimoto, K., Shiraga, M., Kosugi, S., Tadokoro, S., Kato, T., Miyazaki, H., Tomiyama, Y., Kurata, Y., Matsuzawa, Y. and Kanakura, Y. (1997) “Markedly reduced expression of platelet c-Mpl receptor in essential thrombocythemia”, Blood 90, 4031–4038.
   PubMed Web of Science ®Google Scholar